Literature DB >> 25567480

Protein phosphatase 2A is involved in the tyrosine hydroxylase phosphorylation regulated by α-synuclein.

Gao Hua1, Lan Xiaolei, Yang Weiwei, Wang Hao, Zhu Yuangang, Liu Dongmei, Zhang Yazhuo, Yang Hui.   

Abstract

α-Synuclein (α-Syn) plays a crucial role in the pathophysiology of Parkinson's disease (PD), the degeneration of dopaminergic neurons. Previous studies have shown that α-Syn regulates dopamine synthesis by binding to and inhibiting tyrosine hydroxylase (TH). In neurons, protein phosphatases (PPs) play a prominent role in directing signaling toward survival or degeneration. This study was to re-evaluate whether α-Syn could regulate the tyrosine hydroxylase phosphorylation by protein phosphatase-2A (PP2A) in dopaminergic MN9D cells and cortex neurons. Our data demonstrated for the first time that α-Syn stimulates PP2A activity and reduces phosphorylation of TH through regulating the methylation of PP2A in dopaminergic MN9D cells and primary cortex neurons. Increased PP2A activity and reduced phosphorylation of PP2A at Y307 (inactive form of PP2A) were observed in α-Syn overexpression dopaminergic cells (Syn) and primary cortex neurons, and the TH phosphorylation relieved by enhancing PP2A methylation in Syn group could be abated by using PP inhibitors, okadaic acid (OKA). OKA could reduce the cell damage and cell apoptosis induced by α-Syn. Thus our findings may provide an insight into the complicated pathogenesis of PD as well as some clues to the development of novel therapeutic strategies targeting at PP2A.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25567480     DOI: 10.1007/s11064-014-1477-x

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  41 in total

1.  Direct binding and functional coupling of alpha-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis.

Authors:  F J Lee; F Liu; Z B Pristupa; H B Niznik
Journal:  FASEB J       Date:  2001-04       Impact factor: 5.191

2.  A functional role for the B56 alpha-subunit of protein phosphatase 2A in ceramide-mediated regulation of Bcl2 phosphorylation status and function.

Authors:  Peter P Ruvolo; Warren Clark; Marc Mumby; Fengqin Gao; W Stratford May
Journal:  J Biol Chem       Date:  2002-04-02       Impact factor: 5.157

3.  Protein phosphatase 2A (PP2A) is increased in old murine B cells and mediates p38 MAPK/tristetraprolin dephosphorylation and E47 mRNA instability.

Authors:  Daniela Frasca; Maria Romero; Ana Marie Landin; Alain Diaz; Richard L Riley; Bonnie B Blomberg
Journal:  Mech Ageing Dev       Date:  2010-02-26       Impact factor: 5.432

4.  Catalytically inactive protein phosphatase 2A can bind to polyomavirus middle tumor antigen and support complex formation with pp60(c-src).

Authors:  E Ogris; I Mudrak; E Mak; D Gibson; D C Pallas
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

5.  Alpha-synuclein inhibits aromatic amino acid decarboxylase activity in dopaminergic cells.

Authors:  Roya Tehranian; Susana E Montoya; Amber D Van Laar; Teresa G Hastings; Ruth G Perez
Journal:  J Neurochem       Date:  2006-09-18       Impact factor: 5.372

Review 6.  Protein phosphatase 2A: variety of forms and diversity of functions.

Authors:  K Lechward; O S Awotunde; W Swiatek; G Muszyńska
Journal:  Acta Biochim Pol       Date:  2001       Impact factor: 2.149

7.  A role for alpha-synuclein in the regulation of dopamine biosynthesis.

Authors:  Ruth G Perez; Jack C Waymire; Eva Lin; Jen J Liu; Fengli Guo; Michael J Zigmond
Journal:  J Neurosci       Date:  2002-04-15       Impact factor: 6.167

8.  Alpha-synuclein activation of protein phosphatase 2A reduces tyrosine hydroxylase phosphorylation in dopaminergic cells.

Authors:  Xiangmin Peng; Xiangmin M Peng; Roya Tehranian; Paula Dietrich; Leonidas Stefanis; Ruth G Perez
Journal:  J Cell Sci       Date:  2005-07-19       Impact factor: 5.285

Review 9.  Interactions among alpha-synuclein, dopamine, and biomembranes: some clues for understanding neurodegeneration in Parkinson's disease.

Authors:  Jean-Christophe Rochet; Tiago Fleming Outeiro; Kelly A Conway; Tomas T Ding; Michael J Volles; Hilal A Lashuel; Robert M Bieganski; Susan L Lindquist; Peter T Lansbury
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 2.866

10.  Silencing alpha-synuclein gene expression enhances tyrosine hydroxylase activity in MN9D cells.

Authors:  Dongmei Liu; Ling Jin; Hao Wang; Huanying Zhao; Chunli Zhao; Chunli Duan; Lingling Lu; Bo Wu; Shun Yu; Piu Chan; Yaohua Li; Hui Yang
Journal:  Neurochem Res       Date:  2008-03-21       Impact factor: 3.996

View more
  7 in total

1.  Network Analysis Identifies Disease-Specific Pathways for Parkinson's Disease.

Authors:  Chiara Monti; Ilaria Colugnat; Leonardo Lopiano; Adriano Chiò; Tiziana Alberio
Journal:  Mol Neurobiol       Date:  2016-12-21       Impact factor: 5.590

Review 2.  Looking at the recent advances in understanding α-synuclein and its aggregation through the proteoform prism.

Authors:  Vladimir N Uversky
Journal:  F1000Res       Date:  2017-04-20

3.  Evaluation of α-synuclein and apolipoprotein E as potential biomarkers in cerebrospinal fluid to monitor pharmacotherapeutic efficacy in dopamine dictated disease states of Parkinson's disease and schizophrenia.

Authors:  Ashish Kumar Gupta; Ruchika Pokhriyal; Uddipan Das; Mohd Imran Khan; Domada Ratna Kumar; Rishab Gupta; Rakesh Kumar Chadda; Rashmi Ramachandran; Vinay Goyal; Manjari Tripathi; Gururao Hariprasad
Journal:  Neuropsychiatr Dis Treat       Date:  2019-07-19       Impact factor: 2.570

Review 4.  Protein phosphatase 2A as a therapeutic target in inflammation and neurodegeneration.

Authors:  Andrew R Clark; Michael Ohlmeyer
Journal:  Pharmacol Ther       Date:  2019-06-01       Impact factor: 12.310

5.  Copper Dependent Modulation of α-Synuclein Phosphorylation in Differentiated SHSY5Y Neuroblastoma Cells.

Authors:  Marco Greco; Chiara Carmela Spinelli; Lidia De Riccardis; Alessandro Buccolieri; Simona Di Giulio; Debora Musarò; Claudia Pagano; Daniela Manno; Michele Maffia
Journal:  Int J Mol Sci       Date:  2021-02-18       Impact factor: 5.923

6.  Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A): Could It Be a Promising Biomarker and Therapeutic Target in Parkinson's Disease?

Authors:  Sijia Yin; Chao Han; Yun Xia; Fang Wan; Junjie Hu; Liang Kou; Yadi Sun; Jiawei Wu; Yunna Li; Qiulu Zhou; Nian Xiong; Jinsha Huang; Tao Wang
Journal:  Mol Neurobiol       Date:  2022-01-05       Impact factor: 5.590

Review 7.  PP2A and Its Inhibitors in Helper T-Cell Differentiation and Autoimmunity.

Authors:  Mohd Moin Khan; Ubaid Ullah Kalim; Meraj H Khan; Riitta Lahesmaa
Journal:  Front Immunol       Date:  2022-01-05       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.